H Kielhorn: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Reducing uncertainty in environmental risk assessment (era): clearly defining acute and chronic toxicity tests

Torsten Hahn, Jenny Stauber, Stuart Dobson, Paul Howe, Janet Kielhorn, Gustav Koennecker, Jerry Diamond, Chris Lee-Steere, Uwe Schneider, Yoshio Sugaya, Ken Taylor, Rick Van Dam, Inge Mangelsdorf

Journal:

Integrated Environmental Assessment and Management

Year:

2009

Language:

english

File:

PDF, 4.32 MB

english, 2009

52

Ist der Vergleich verschiedener Studien zur Wirksamkeit von Biologika bei Patienten mit rheumatoider Arthritis möglich?

K. Krüger, B. Hellmich, A. Rubbert-Roth, U. Müller-Ladner, A. Kielhorn

Journal:

Zeitschrift für Rheumatologie

Year:

2011

Language:

german

File:

PDF, 496 KB

german, 2011

53

Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs

Gert J.D. Bergman, Marc C. Hochberg, Maarten Boers, Neil Wintfeld, Adrian Kielhorn, Jeroen P. Jansen

Journal:

Seminars in Arthritis and Rheumatism

Year:

2010

Language:

english

File:

PDF, 595 KB

english, 2010

54

Fluctuation theory of diblock copolymer/homopolymer blends and its effects on the Lifshitz point

Kielhorn, L., Muthukumar, M.

Journal:

The Journal of Chemical Physics

Year:

1997

Language:

english

File:

PDF, 734 KB

english, 1997

55

Clinical assessment of the Zeiss IOLMaster

Ingrid Kielhorn, Madhavan S Rajan, Peter M Tesha, Visva Raja Subryan, John A Bell

Journal:

Journal of Cataract & Refractive Surgery

Year:

2003

Language:

english

File:

PDF, 517 KB

english, 2003

56

III-24. Human perception of astringency: A multidimensional scaling study

S. Kielhorn, J.H. Thorngate III

Journal:

Food Quality and Preference

Year:

1996

Language:

english

File:

PDF, 133 KB

english, 1996

57

Oral sensations associated with the flavan-3-ols (+)-catechin and (−)-epicatechin

S Kielhorn, J.H Thorngate III

Journal:

Food Quality and Preference

Year:

1999

Language:

english

File:

PDF, 206 KB

english, 1999

58

CVD-processes by hollow cathode glow discharge

A. Hellmich, T. Jung, A. Kielhorn, M. Rißland

Journal:

Surface and Coatings Technology

Year:

1998

Language:

english

File:

PDF, 819 KB

english, 1998

59

HP4 PRIMARY CARE AND GATEKEEPER MODELS IN GERMANY — WHAT DO THE PATIENTS WANT?

H Kielhorn, AB Wolter, MP Schoenermark

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 54 KB

english, 2005

60

PAR18 PATIENT COMPLIANCE IN THE TREATMENT OF RHEUMATOID ARTHRITIS WITH BIOLOGIC DMARDS AND PREDICTING FACTORS: A LITERATURE REVIEW

E Schmidt, A Kielhorn

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 63 KB

english, 2005

61

PP2: THE EFFECT OF AGE ON COST-EFFECTIVENESS IN THE TREATMENT OF MODERATE ASTHMA

A Kielhorn, M Behrens

Journal:

Value in Health

Year:

1999

Language:

english

File:

PDF, 69 KB

english, 1999

62

PRS15: OUTCOMES RESEARCH STUDY ASSESSING RESOURCE UTILIZATION FOR THE TREATMENT OF ASTHMA EXACERBATION IN PRIMARY CARE IN SPAIN

A Kielhorn, J Molina, K Naberan, JA Alonso, K Price

Journal:

Value in Health

Year:

2000

Language:

english

File:

PDF, 58 KB

english, 2000

63

PDG3: AN ECONOMIC EVALUATION OF COMBINATION THERAPY WITH PIOGLITAZONE (ACTOS, TAKEDA) IN TYPE 2 DIABETES MELLITUS FROM A SPANISH HEALTH-CARE PERSPECTIVE

N Maniadakis, J Sacristan, J Reviriego, W Hart, R Jansen, A Kielhorn, A Brandt

Journal:

Value in Health

Year:

2001

Language:

english

File:

PDF, 55 KB

english, 2001

64

PDG14: AN ASSESSMENT OF THE COSTEFFECTIVENESS OF PIOGLITAZONE (ACTOS*NF, TAKEDA) IN TYPE 2 DIABETES MELLITUS IN DENMARK

R Jansen, JO Clausen, N Maniadakis, A Kielhorn, A Brandt

Journal:

Value in Health

Year:

2001

Language:

english

File:

PDF, 66 KB

english, 2001

65

PDG11: HEALTH AND ECONOMIC OUTCOMES OF A NEW ORAL DIABETES DRUG, PIOGLITAZONE (ACTOS*NF, TAKEDA), IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN NORWAY

A Brandt, K Frislid, R Jansen, N Maniadakis, A Kielhorn

Journal:

Value in Health

Year:

2001

Language:

english

File:

PDF, 52 KB

english, 2001

66

PDG6: COST-EFFECTIVENESS OF PIOGLITAZONE (ACTOS®, TAKEDA) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN SWEDEN

F Henriksson, A Brandt, L Thomander, A Kielhorn, R Jansen, N Maniadakis

Journal:

Value in Health

Year:

2001

Language:

english

File:

PDF, 52 KB

english, 2001

67

PHP52 HIGH AND INTENSIVE UTILIZERS IN HEALTH CARE—A STRATEGIC CHALLENGE FOR MEDICAL SUPPLY IN THE COMPULSORY HEALTH INSURANCE

MP Schoenermark, N Beindorff, H Kielhorn

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 76 KB

english, 2010

68

D. Biosynthesis of steroid-hormone receptors

A. Hughes, P. Szendro, Cecilia Teran, Janet Kielhorn, W. Sierralta, G. Stone, M. Little, P.W. Jungblut

Journal:

Journal of Steroid Biochemistry

Year:

1975

Language:

english

File:

PDF, 287 KB

english, 1975

69

Environmental fate and distribution of sodium [14C] pentachlorophenate in a section of urban wasteland ecosystem

A. Haque, H. Gruttke, W. Kratz, U. Kielhorn, G. Weigmann, G. Meyer, R. Bornkamm, I. Schuphan, W. Ebing

Journal:

Science of The Total Environment

Year:

1988

Language:

english

File:

PDF, 659 KB

english, 1988

70

Taking ACTION to establish direct costs and outcomes of treating advanced non-small cell lung cancer in routine clinical practice

Cullen, Michael, Szczepura, Ala, Thomas, Michael, Kielhorn, Adrian

Journal:

Year:

2004

Language:

english

File:

PDF, 58 KB

english, 2004

71

Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe

Schiller, Joan, Tilden, Dominic, Aristides, Michael, Lees, Michael, Kielhorn, Adrian, Maniadakis, Nikos, Bhalla, Shkun

Journal:

Year:

2004

Language:

english

File:

PDF, 161 KB

english, 2004

72

Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy

Novello, S., Kielhorn, A., Stynes, G., Selvaggi, G., De Marinis, F., Maestri, A., Foggi, P., Tilden, D., Tonato, M., Crinò, L., Rinaldi, M., Migliorino, A.M., Scagliotti, G.V.

Journal:

Year:

2005

Language:

english

File:

PDF, 177 KB

english, 2005

73

Target organs in transgenic mutation assays in comparison to target organs in carcinogenicity studies

Ulrich Wahnschaffe, Annette Bitsch, Janet Kielhorn, Inge Mangelsdorf

Journal:

Toxicology Letters

Year:

2006

Language:

english

File:

PDF, 88 KB

english, 2006

74

PCN4 RETROSPECTIVE COST ANALYSIS OF GEMZARTM IN COMBINATION WITH CISPLATIN IN NON-SMALL CELL LUNG CANCER COMPARED TO OTHER COMBINATION THERAPIES IN GERMANY

A Kielhorn, N Maniadakis, M Aristides, M Lees, D Tilden

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 67 KB

english, 2002

75

WD3 PATIENT PREFERENCE AND WILLINGNESS-TO-PAY IN FIVE EUROPEAN COUNTRIES FOR HUMALOG MIX25 COMPARED TO HUMULIN 30/70 FOR THE TREATMENT OF TYPE 2 DIABETES

M Aristides, A Weston, P FitzGerald, C LeReun, M Schulz, N Maniadakis, A Kielhorn

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 60 KB

english, 2002

76

PCN4 IN THE UK GEMZAR DOUBLET HAS LOWEST TOTAL TREATMENT COSTS FOR NSCLC COMPARED TO FOUR OTHER CHEMOTHERAPY DOUBLETS

M Aristides, D Tilden, M Lees, A Kielhorn, S Bhalla

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 83 KB

english, 2002

77

PCN13 GEMZAR RETROSPECTIVE ECONOMIC ANALYSIS OF CLINICAL TRIALS (GREAT) IN THE TREATMENT OF NON-SMALL-CELL LUNG CANCER:A MULTI-COUNTRY COSTMINIMISATION ANALYSIS

M Aristides, M Lees, DP Tilden, A Kielhorn, G Stynes

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 64 KB

english, 2002

78

PCN16 A COMPARISON OF THE COSTS OF GEMCITABINE/CISPLATIN AND GEMCITABINE/CARBOPLATIN COMBINATION REGIMENS IN THE TREATMENT OF ADVANCED NSCLC IN THE UK AND FRANCE

DP Tilden, M Aristides, G Stynes, A Kielhorn, S Bhalla

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 66 KB

english, 2002

79

PCN7 MAJOR DETERMINANTS OF COST IN ADVANCED NON-SMALL-CELL LUNG CANCER CHEMOTHERAPY REGIMES IN FRANCE

D Tilden, M Aristides, A Kielhorn, S Bhalla

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 82 KB

english, 2002

80

PCN19 EXAMINING PREFERENCES AND TIMETRADE-OFF UTILITY FOR GEMCITABINE PLUS CISPLATIN IN THE TREATMENT OF BLADDER CANCER:A SURVEY USING DISCRETE CHOICE CONJOINT ANALYSIS IN THE UK

A Brown, M Aristides, P FitzGerald, P Davey, S Bhalla, A Kielhorn

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 79 KB

english, 2002

81

PCN8 AVERAGE TOTAL COST OF TREATING ADVANCED NON-SMALL-CELL LUNG CANCER PATIENTS IN SPAIN USING VARIOUS CHEMOTHERAPY DOUBLETS

A Kielhorn, M Aristides, DP Tilden, S Bhalla

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 61 KB

english, 2002

82

PCN20 IS THERE DIFFERENCE BETWEEN GEMCITABINE BASED NSCLC TREATMENT AND OTHER PLATINUM BASED COMBINATIONS FOR RESPONSE RATES AND TOXICITY?

S Bhalla, A Kielhorn, N Maniadakis

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 62 KB

english, 2002

83

PAR6 COST-UTILITY ANALYSIS OF RITUXIMAB AS A NEW THERAPEUTIC OPTION FOR RHEUMATOID ARTHRITIS PATIENTS IN CANADA

B Mistry, J McCormick, A Diamantopoulos, A Kielhorn

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 71 KB

english, 2006

84

PAR10 COST-EFFECTIVENESS OF RITUXIMAB THERAPY FOR RHEUMATOID ARTHRITIS: A PAN-EUROPEAN ANALYSIS

A Kielhorn, A Rubbert, D Porter, S De Vita, B Brown, M Aristides, R Aultman, F Jost

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

85

PAR4 COST-EFFECTIVENESS ANALYSIS OF RITUXIMAB AS A NEW THERAPEUTIC OPTION FOR RHEUMATOID ARTHRITIS IN THE UK

D Porter, G Lewis, B Brown, A Diamantopoulos, A Kielhorn

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 65 KB

english, 2006

86

PAR5 COST-EFFECTIVENESS OF RITUXIMAB AS A NEW TREATMENT MODALITY FOR RHEUMATOID ARTHRITIS IN GERMANY

A Rubbert, A Kielhorn, S Schach, B Brown

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 65 KB

english, 2006

87

PAR7 MODELLING OF THE COST-EFFECTIVENESS OF RITUXIMAB FOR TREATMENT OF RHEUMATOID ARTHRITIS IN ITALY

S De Vita, G Giuliani, A Diamantopoulos, B Brown, A Kielhorn

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 70 KB

english, 2006

88

PAR8 USING MABTHERA IN PATIENTS WITH RHEUMATIC ARTHRITIS IN SPAIN: RESULTS OF COST-EFFECTIVENESS DATA BASED ON MICRO-SIMULATION

A Kielhorn, C Alvarez, M Aristides, A Diamantopoulos

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 70 KB

english, 2006

89

MD2 ECONOMIC CONSEQUENCES OF PROVIDING RITUXIMAB AS ATREATMENT ALTERNATIVE FOR RHEUMATOID ARTHRITIS IN THE NETHERLANDS

M Pompen, A Diamantopoulos, W Kievit, R Moers, A Kielhorn

Journal:

Value in Health

Year:

2007

Language:

english

File:

PDF, 93 KB

english, 2007

90

PAR22 COST-EFFECTIVENESS OF RITUXIMAB (MABTHERA) COMPARED WITH ABATACEPT (ORENCIA) FOR THE TREATMENT OF MODERATE/SEVERE RHEUMATOID ARTHRITIS (RA) IN THE UNITED KINGDOM

G Lewis, A Kielhorn, A Diamantopoulos

Journal:

Value in Health

Year:

2007

Language:

english

File:

PDF, 92 KB

english, 2007

91

PAR3 COST-BENEFIT OF RITUXIMAB FOR RHEUMATOID ARTHRITIS PATIENTS IN ARGENTINA

JP Solé, GP Ortega, A Kielhorn

Journal:

Value in Health

Year:

2007

Language:

english

File:

PDF, 91 KB

english, 2007

92

PCNI7 DOES GEMCITABINE PLUS CISPLATIN PROVIDE VALUE FOR MONEY IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG CANCER IN THE UK?

J Watkins, A Kielhorn, S Bhalla, D Tilden, G Stynes

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 63 KB

english, 2004

93

PCNI8 A COST COMPARISON OF GEMZAR PLUS CISPLATIN WITH OTHER NOVEL AGENTS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN ITALY

A Kielhorn, G Stynes, S Bhalla, D Tilden

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 81 KB

english, 2004

94

PCN24 GEMZAR RETROSPECTIVE ECONOMIC ANALYSIS OF CLINICAL TRIAL (GREAT) IN THE TREATMENT OF NON-SMALL-CELL LUNG CANCER IN TAIWAN

CH Yang, L Wang, N Wang, A Kielhorn

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 80 KB

english, 2004

95

PCNI5 GEMZAR RETROSPECTIVE ECONOMIC ANALYSIS OF CLINICAL TRIALS (GREAT2): A PATIENT-LEVEL COST COMPARISON OF THREE CHEMOTHERAPY REGIMENS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN FRANCE

R Launois, S Avoinet, K Le Lay, D Tilden, S Bhalla, A Kielhorn, N Chemali

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 81 KB

english, 2004

96

PCN20 COSTS OF TREATING ADVANCED NON-SMALL-CELL LUNG CANCER IN SPAIN USING GEMCITABINE IN COMBINATION WITH CISPLATIN: A COMPARISON WITH OTHER 2ND GENERATION NOVEL AGENTS

A Kielhorn, T Dilla, G Stynes, D Tilden, S Bhalla

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 64 KB

english, 2004

97

PCNI6 COMPARATIVE COSTS OF GEMCITABINE/CISPLATIN, PACLITAXEL/CARBOPLATIN AND VINORELBINE/CISPLATIN IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN GERMANY

H Bischoff, M Hamann, G Stynes, S Bhalla, D Tilden, A Kielhorn

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 63 KB

english, 2004

98

Cost Effectiveness of Fluticasone and Budesonide in Patients with Moderate Asthma

Karl-Otto Steinmetz, Dr Timm Volmer, Marion Trautmann, Adrian Kielhorn

Journal:

Clinical Drug Investigation

Year:

1998

Language:

english

File:

PDF, 262 KB

english, 1998

99

Subjective Differences in Outcome Are Seen as a Function of the Immunohistochemical Method Used on a Colorectal Cancer Tissue Microarray

Gina G. Chung, Eric P. Kielhorn, David L. Rimm

Journal:

Clinical Colorectal Cancer

Year:

2002

Language:

english

File:

PDF, 455 KB

english, 2002

100

The Biology of the Surface Zone Zooplankton of a Boreo-Arctic Atlantic Ocean Area

Kielhorn, William V.

Journal:

Journal of the Fisheries Research Board of Canada

Year:

1952

Language:

english

File:

PDF, 2.20 MB

english, 1952

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски